Marijuana has been shown to help ease pain and a few other health
problems, yet two-thirds of U.S. states have decided pot should be
legal to treat many other conditions with little scientific backing.
At least 1.4 million Americans are using marijuana for their health , according to an Associated Press analysis of states that track medical marijuana patients.
The number of medical marijuana cardholders more than tripled in the
last five years as more states jumped on the bandwagon. The analysis is
based on data from 26 states and the District of Columbia.
The total
climbs to 2.6 million patients if California, Washington and Maine are
included, the AP estimates.
States that expanded the use of medical pot for common ailments such as
severe pain, post-traumatic stress disorder and anxiety saw a boost in
enrollment, the AP found.
The U.S. government, meanwhile, both considers marijuana an illegal drug and a therapeutic herb worth more study.
A look at the health claims and research on medical marijuana:
THE EVIDENCE
Besides chronic pain, there's strong evidence marijuana or its
ingredients can ease nausea and vomiting from chemotherapy and help with
symptoms of multiple sclerosis.
Several European countries have approved Sativex, a mouth spray
containing THC and CBD, for multiple sclerosis symptoms. Last year, U.S.
regulators approved Epidiolex, made from CBD, to treat two rare seizure
disorders. THC causes marijuana's mind-altering effect; CBD doesn't get
people high.
British drugmaker GW Pharmaceuticals is seeking U.S. approval for
Sativex. Other companies are pursuing Food and Drug Administration
backing for products based on marijuana ingredients.
Arizona-based Insys Therapeutics, which filed for bankruptcy protection
Monday as it faced fallout over its marketing of an addictive opioid
painkiller, is developing CBD drugs for two types of childhood epilepsy
and a rare genetic disorder. Pennsylvania-based Zynerba Pharmaceuticals
is working on a CBD skin patch for autism and fragile X syndrome, a
genetic condition.
Prescription drugs already on the market use synthetic THC to treat
weight loss, nausea and vomiting in patients with AIDS or cancer. And
researchers continue to study whether marijuana helps with PTSD, back
pain and other problems.
OPIOID ALTERNATIVE?
New York, New Jersey, Pennsylvania and New Mexico allow medical marijuana for opioid addiction despite little evidence it works.
But marijuana may be helpful in reducing use of opioid painkillers. The
National Center for Complementary and Integrative Health, better known
for its research on herbs and yoga, has set aside $3 million for studies
to determine which of marijuana's 400-plus chemicals help with pain.
THC was excluded however.
Its mood-altering effects and potential for addiction and abuse make it
less useful for pain, said Dr. David Shurtleff, the agency's deputy
director. And THC has been studied more than the lesser-known compounds.
CURE FOR CANCER?
Despite online claims, there's only weak evidence that marijuana's
ingredients might one day be used to treat cancer. Most studies have
been in animals or in the lab. Results have been mixed.
In one study, nine patients with an aggressive form of brain cancer had
THC injected into their tumors; any effect on their survival was
unclear. Another study found worrying evidence that marijuana might
interfere with some cancer drugs, making them less effective.
RESEARCHING AN OUTLAW MEDICINE
The U.S. government grows marijuana for research at a farm in
Mississippi and generally bans grant-funded studies of real-world
products.
But a mobile lab inside a white Dodge van allows University of Colorado
Boulder researchers to study the potent strains of marijuana many
patients consume without running afoul of the law.
Study participants use marijuana in their homes, coming to the van for
blood draws and other tests before and after using, said Cinnamon
Bidwell who has federal grants to study marijuana's effects on lower
back pain and anxiety.
With increased demand for research pot, the Drug Enforcement
Administration created an application process for growers, but has not
acted on more than two dozen applications.
Such challenges are common for scientists studying an outlaw medicine,
said Dr. Igor Grant, who directs the oldest marijuana research center in
the U.S. at the University of California, San Diego.
There, scientists are studying marijuana chemicals for children with
autism and adults with a brain disorder that causes uncontrollable
shaking. Established by state law in 2000, the Center for Medicinal
Cannabis Research once relied solely on California for funding. The
center now has support from private foundations, a sign of growing
public acceptance of the research.
TRACKING PATIENTS
Minnesota medical marijuana patients must regularly fill out surveys
about their symptoms and side effects. That allows researchers to study
how people with cancer react to marijuana.
In one study, a third of cancer patients made only one purchase and
didn't come back during a four-month period. They may have died, or
decided marijuana was too expensive or didn't work. Of the rest, most
reported improvements in vomiting, pain, disturbed sleep, anxiety and
depression with few side effects.
Marijuana can ease many symptoms "all at one time," but more study is
needed, said study co-author Dr. Dylan Zylla of the health care system
HealthPartners. He has no financial ties to cannabis companies.
Zylla is studying whether cancer patients can decrease their prescription opioid use while using marijuana.
Marijuana "does seem to help patients," he said, "but so much is unknown about the risks, side effects and drug interactions."
AP data journalist Angeliki Kastanis in Los Angeles contributed to this report.
No comments:
Post a Comment